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1 INTRODUCTION 
Cardiovascular diseases (CVD) are the leading cause of death and illness in developed 
countries, being atherosclerosis the most important contributor. Atherosclerosis is a 
chronic inflammatory condition that can be converted into an acute clinical event by 
plaque rupture and thrombosis. Indeed, vascular inflammation not only plays a major 
role in the development of atherosclerosis, but also contributes to the acute onset of 
thrombotic complications (Libby, 2002). 
???? ?????? ???????? ??? ???????????????? ???? ??????? ??????? ???????? ???? ???????? ???
accumulations of macrophages stuffed with lipids. These lesions, not clinically 
significant, are the precursor of more advanced lesions of lipid-rich necrotic debris and 
???????????????????? ????????????? ???????? ?????????????????????????????????????????????
SMCs and extracellular matrix that encloses a lipid-rich necrotic core and eventually 
lead to clinical manifestations. Common risk factors for atherosclerosis include 
hypercholesterolemia, familial predisposition and high blood pressure. In addition, 
smoking, obesity, diabetes and sedentary lifestyles all contribute to the increasing 
prevalence of atherosclerosis. These risk factors may contribute to the initiation of 
plaque formation, but the biological processes underlying atherogenesis is very 
complex (Lusis, 2000).  
Anyway, it is well known that high levels of low density lipoprotein (LDL) cholesterol 
and low levels of high density lipoprotein (HDL) cholesterol strongly associate with an 
increased risk of CVD. Clinical studies suggest that apolipoprotein B100 and 
apolipoprotein AI levels, the major protein structural component of very low density 
lipoprotein (VLDL)/LDL and HDL respectively, could be better predictors of CVD risk 
(Walldius et al., 2001). Other protein components of LDL and HDL play important roles 
in lipid metabolism, energy homeostasis, and inflammation. Therefore, obtaining 
detailed information about apolipoprotein composition and structure may contribute to 
reveal their role in atherogenesis and eventually to develop new therapeutic strategies 
for the treatment of lipoprotein-associated disorders. The knowledge of lipoprotein 
protein composition has been improved in the last years especially with the 
improvement of proteomics technologies. However, the majority of the lipoproteomic 
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studies have been devoted so far to the characterization of the lipoprotein protein 
composition in healthy subjects, while few studies exist in relation to atherosclerosis. 
 
1.1 ATHEROSCLEROSIS 
Atherosclerosis is a progressive disease characterized by the accumulation of lipids and 
fibrous elements in the large arteries. The etiology of atherosclerosis is very complex 
and, as revealed by several epidemiological studies, numerous risk factors are involved 
either with a genetic component or environmental. Factors with a strong genetic 
component are: elevated levels of LDL, VLDL and lipoprotein (a) (Lp(a)), reduced levels 
of HDL, elevated levels of homocysteine, hypertension, diabetes and obesity, family 
history, systemic inflammation, and gender. Environmental factors involved are: high-
fat diet; smoking; lack of exercise, and infectious agents (Lusis, 2000). There is also a 
strong body of evidence indicating that elevated triglycerides (TG) are an independent 
risk factor for atherosclerosis (Boullart et al., 2011; Sarwar et al., 2007). 
The earliest and presumably initiating event in atherogenesis is the selective retention 
of circulating apo B100 containing lipoproteins, particularly LDL and Lp(a), in the 
subendothelial space, by means of specific interactions with artery wall proteoglycans 
(Williams & Tabas, 1995; Skalen et al., 2002). The retained lipoproteins induce a series of 
biological responses that lead to atherosclerotic lesion formation (figure 1). These 
responses are: (a) endothelial alterations; (b) recruitment of macrophages and 
lymphocytes to the intima which in turn induces an inflammatory state in the arterial 
wall; (c) accumulation of cholesteryl fatty acyl esters in macrophages and, to a lesser 
extent, smooth muscle cells (so-?????????????????????????????????????????????-to-intimal 
migration of smooth muscle cells that produce a fibrous cap of extracellular matrix over 
the lesion (Lusis, 2000). 
Lipoproteins diffuse passively in the subendothelium space through endothelial cells 
junctions; therefore the accumulation of LDL in the subendothelium depends on the 
circulating level of LDL. Regions of arterial branching or curvature, where flow is 
disturbed and cells have polygonal shapes and no particular orientation, show 
increased permeability to macromolecules such as LDL and are preferential sites for 
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lesion formation (Gimbrone et al., 1999). Once retained, lipoproteins are more 
susceptible to oxidative and enzymatic modifications. One of the modifications most 
???????????? ???? ?????? ??????? ?????????? ??? ?????? ?????????? ????? ?????? ????? ??? ? ??? ?????
?????????????????cies that have pro-inflammatory activity (Lusis, 2000). Mice lacking 
lipoxygenase have considerably diminished atherosclerosis, suggesting that this 
enzyme may be an important source of reactive oxygen species (ROS) in LDL oxidation 
(Cyrus et al., 1999). Under the stimulus of minimally oxidized LDL, the endothelial cells 
(ECs) produce a number of pro-inflammatory molecules, including adhesion molecules, 
chemotactic proteins such as monocyte chemotactic protein-1 (MCP-1), and growth 
factors such as macrophage colony-stimulating factor (M-CSF), resulting in the 
recruitment of monocytes to the vessel wall (Libby, 2002; Dzau et al., 2002). Oxidized 
LDL can also inhibit the production of nitric oxide (NO), a chemical mediator with 
multiple anti-atherogenic properties, including vasorelaxation. Among endothelial cell 
adhesion molecules likely to be important in the recruitment of leukocytes are ICAM-1, 
P-selectin, E-selectin, and VCAM-1 which bind to carbohydrate ligands on leukocytes 
(Cybulsky et al., 2001; Dong et al., 1998; Collins et al., 2000). As a result of the action of 
ROS produced by ECs and macrophages and of various enzymes such as 
sphingomyelinase (SMase), secretory phospholipase 2 (sPLA2), and myeloperoxidase 
(MPO), highly oxidized aggregated LDL is formed in the vessel. Such modified LDL is 
recognized by macrophage scavenger receptors such as SR-A, CD36 and CD68 whose 
expression is mediated by cytokines such as tumor necrosis factor-? (TNF-?) and 
interferon-? (IFN-?). The highly modified LDL is rapidly taken up by macrophages to 
form foam cells that finally undergo apoptosis leaving behind a growing mass of 
extracellular lipids and other cell debris (Libby, 2002). The uptake by macrophages is 
???????????????????????????????????????????????????????????-A and CD36 that appear to 
be of primary importance. It has been shown that mice lacking these receptors show a 
modest reduction in atherosclerotic lesions (Suzuki et al., 1997; Febbraio et al., 2000). 
Macrophages and T cells secrete cytokines and growth factors that stimulate SMC 
migration/proliferation and extracellular matrix production. The intimal SMCs secrete 
extracellular matrix and give rise to a fibrous cap whose maintenance reflects matrix 
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production and degradation. The products of inflammatory cells are likely to influence 
these processes. For example IFN-? produced by T cells inhibits the production of 
matrix by SMCs and macrophages produce various proteases that degrade extracellular 
matrix (Libby et al., 1996). The composition and vulnerability of a plaque is likely to be 
more important than the severity of stenosis in the development of thrombus mediated 
acute events. The most prominent features of vulnerable plaques include: thinning of 
the fibrous cap, ?????????????????????????????consisting of dead macrophages, macrophage 
debris, and extracellular lipid and a state of inflammation, consisting of activated 
leukocytes and inflammatory cytokines (Aikawa & Libby, 2004; Libby, 2002). It is likely 
that thinning of the fibrous cap directly promotes plaque breakdown leading to 




Figure 1. Atherosclerotic lesion development (Glass and Witztum, 2001) 
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1.2 LIPOPROTEINS 
Lipoproteins are supramolecular complexes that deliver insoluble lipids from the 
tissues where they are synthesized to those that utilize, or store them. They consist of 
hydrophobic molecules, particularly triacylglycerol and cholesteryl esters, stabilized 
with a coat of amphipathic compounds: phospholipids, unesterified cholesterol and 
proteins, referred to as apolipoproteins (apo) (Vance & Vance, 2008).  
The apolipoproteins have more than a stabilizing role, allowing lipoproteins to be 
recognized by specific receptors on cell surfaces, and acting as regulator of the activity 
of enzymes involved in lipoprotein metabolism (Bolanos-Garcia & Miguel, 2003).  
There are several types of lipoproteins differing for chemical compositions, physical 
properties and metabolic functions. They may be classified according to their densities 
that depend on the lipid/protein ratio within the particle: in general the higher this 
ratio, the lower the density and the bigger the diameter. From lowest to highest density, 
lipoproteins are: chylomicrons (CM), very low density lipoproteins, low density 
lipoproteins and high density lipoproteins. An additional class of intermediate density 
lipoproteins (IDL) is sometimes included between VLDL and LDL. Chylomicrons and 
VLDL particles are often grouped as the triacylglycerol-rich lipoproteins, whereas LDL 
and HDL are more important as carriers of cholesterol. It is important to emphasize that 
lipoproteins, within each class, are heterogeneous in terms of their density, size, lipid 
and apolipoprotein compositions, as well as in their functional properties. Moreover, 
the lipoprotein particles are extensively remodeled in the plasma compartment (Gurr et 
al., 2002; Vance & Vance, 2008).  
A further class of lipoprotein particles is known as lipoprotein(a) that displays a higher 
density than LDL. Its structure is that of an LDL particle, to the apo B-100 of which is 
covalently attached, by a single disulfide bond, a glycosylated multi-kringle protein, 
apolipoprotein(a) or apo(a) (Scanu, 2005). The physiological role of Lp (a) is unknown, 
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1.2.1 LIPOPROTEIN METABOLISM 
Chylomicrons (diameter >100 nm; d< 0.95 g/ml) are the largest and least dense among 
lipoproteins and their function is to transport lipids of exogenous origin, principally 
triacylglycerols. The TG core is stabilized with a surface monolayer of amphipathic 
molecules: phospholipids, unesterified cholesterol and proteins. The core lipid also 
contains some cholesteryl esters and minor fat-soluble substances like vitamins and 
carotenoids. Their major apolipoprotein is apo B-48. Chylomicrons are secreted by the 
intestine and are abundant in plasma only after a meal. They are metabolized in several 
districts, such as the liver, the adipose tissue and the skeletal muscle (Gurr et al., 2002). 
As the chylomicron particles, secreted from enterocytes, enter the plasma, they interact 
with other particles and acquire other apolipoproteins, especially apo CII, apo CIII and 
apo E. In the capillaries of a number of extra-hepatic tissues, chylomicrons come into 
contact with the enzyme lipoprotein lipase (LPL), anchored to the luminal side of the 
endothelial cells (Redgrave, 2004). LPL, of which apo CII is an essential cofactor, 
hydrolyses the triacylglycerol core in the particle (Mead et al., 2002). The non-esterified 
fatty acids liberated during hydrolysis are used as energy source by various cells or are 
taken up by adipocytes and stored as triglycerides, while surface components dissociate 
and are acquired by other lipoproteins. The resulting particle is known as a 
chylomicron remnant that is removed from plasma and taken up by the liver through 
interaction with cell-surface receptors, probably lipoprotein receptor-related protein 
(LRP), a process that requires apo E (Redgrave, 2004; Cooper, 1997).  
Very low density lipoproteins, (30 nm <diameter<90 nm; d< 1.006 g/ml), are the main 
vehicle for neosynthesized lipids, especially TGs, that they transport from the liver to 
various tissues, mainly muscles and adipose tissues. Together with TGs, VLDL particles 
contain also some free cholesterol and cholesterol esters (CE). Each VLDL particle is 
assembled around one molecule of apo B100 and contains other apolipoproteins 
especially apo B, E, and C (Cushley & Okon, 2002). VLDL particles are assembled in the 
liver using free fatty acid derived from chylomicrons or from de novo production. 
Within the plasma compartment, as described for chylomicrons, VLDL particles interact 
with LPL that hydrolyses their triacylglycerol core. Through successive interactions 
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with lipoprotein lipase they lose their triacylglycerols and subsequently their surface 
components (Gurr et al., 2002). A proportion of the resulting particles, namely the IDL 
(d=1.006-1.019 g/ml), are removed from the circulation by the hepatocytes through the 
interaction with LDL receptor (LDLR), while the remaining part is converted to LDL 
following a further reduction of the TG component by hepatic lipase (Perret et al, 2002).  
Low density lipoproteins, ?????????? ???? ???? ???????-1.063 g/ml), represent the end 
product of VLDL catabolism and are the major cholesterol-transporting lipoproteins in 
the plasma. The main structural apolipoprotein component is apo B100 that has an 
important role in the recognition of LDL by cells. Circulating LDL particles are removed 
by LDL-receptors on cell surfaces in the sub-endothelial space. The major site for 
removal of LDL particles is normally the liver although the LDL-receptor is expressed 
by most cells being a way by which cells can acquire cholesterol (Vance & Vance, 2008). 
The LDL-receptor is also known as the B/E receptor because it recognizes homologous 
regions on apo E and on apo B 100. The expression of LDL-receptors is finely regulated 
to maintain cellular cholesterol homeostasis and mutations in this receptor cause loss of 
function resulting in elevation in the plasma LDL-cholesterol concentration (familial 
hypercholesterolaemia) (Soutar & Naoumova, 2007). Once synthesized, the receptor is 
exported to specialized regions of the cell membrane where the cytoplasmic leaflet is 
coated with the protein clathrin. After binding of an LDL particle through interaction 
between its apolipoprotein B 100 molecule and the ligand-binding domain of the LDL-
receptor, the receptor-LDL complex is internalized by endocytosis of the coated pit. 
Inside the acidic environment of the endosome, the LDL particle and receptor dissociate 
and the receptor is recycled back to the cell surface. The remainder of the particle is 
transferred to lysosomes, where the cholesteryl esters are hydrolysed by lysosomal acid 
hydrolases (Gurr et al, 2002).  
High density lipoproteins (diameter 10 nm; d=1.063-1.21 g/ml) are responsible for the 
reverse transport of cholesterol in excess from different tissues to the liver and 
steroidogenic tissues for metabolism and excretion. Its main apolipoprotein component 
is apo AI. HDL maturation is a complex process involving the secretion of lipid-poor 
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particles and extracellular lipid acquisition, mainly cholesterol and phospholipids 
(Rader, 2006) 
Immature lipid-poor HDL particles acquire unesterified cholesterol interacting with cell 
membranes. The protein involved in this case is a member of a family of cell-
membrane-associated transporter proteins that bind ATP, (this particular protein is now 
known as ABCA1) (Oram, 2002; Oram & Heinecke, 2005). The unesterified cholesterol 
acquired by the particles is esterified with a long-chain fatty acid by the HDL associated 
enzyme lecithin-cholesterol acyltransferase (LCAT), activated principally by apo AI 
(Yokoyama et al., 1980), and also by others apolipoproteins such as AIV, CI and E 
(Yokoyama, 1998). This enzyme catalyses the transfer of a fatty acid from 
phosphatidylcholine, present in the HDL particle, to cholesterol to form a cholesteryl 
ester. The hydrophobic cholesteryl ester moves to the core of the particle, which 
becomes spherical as more cholesterol is acquired and esterified. This is probably the 
origin of the bulk of HDL-cholesterol in plasma, although some is also acquired from 
the surface components of chylomicrons and VLDL particles when their triacylglycerol 
is hydrolyzed by lipoprotein lipase (Gurr et al., 2002). When HDL-cholesterol reach the 
liver, offloads the cholesteryl ester content interacting with the scavenger receptor SR-BI 
(Krieger, 1999). Another mechanism for delivering HDL-cholesterol to the liver involves 
a plasma protein known as cholesteryl ester transfer protein (CETP), which is secreted 
from the liver and from adipose tissue. CETP, of which physiological inhibitor are 
known to be apo F (Wang et al., 1999) and apo C-I (Dumont et al., 2005), mediates the 
exchange of triacylglycerol and cholesteryl esters between particles, according to 
concentration gradients. When HDL particles become enriched in cholesteryl esters, 
they may exchange these esters for triacylglycerol carried in the triacylglycerol-rich 
lipoproteins, i.e. chylomicrons and VLDL.  
A schematic overview of lipoprotein metabolism is reported in figure 2. 
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Figure 2. Schematic overview of lipid uptake and transport (Schittmayer & Birner-
Gruenberger, 2009). 
 
1.3 THE APOLIPOPROTEINS 
The apolipoproteins found in plasma are classified into two broad types: the non-
exchangeable and the exchangeable apolipoproteins. Some apolipoproteins are known 
as exchangeable because of their ability to move and exchange between lipoprotein 
particles. Apo B100, the principal protein components of LDL, VLDL, Lp (a), and apo B-
48, the principal protein component of CM, are non-exchangeable apolipoproteins. 
They are very large and water-insoluble proteins that are assembled with lipids at their 
site of synthesis in the endoplasmic reticulum of liver or intestinal cells. These 
apolipoproteins circulate bound to the same lipoprotein particle through various 
metabolic transformations in plasma, until they are cleared via specific lipoprotein 
receptors. In contrast, the exchangeable apolipoproteins have much smaller molecular 
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masses than apo B100 or apo B48, have limited solubility in water in their delipidated 
states, can transfer among lipoprotein particles, and can acquire lipids while in 
circulation (Mahley et al., 1984).  
The common function of all apolipoproteins is to help solubilize neutral lipids in the 
circulation but they have also roles in receptor recognition and hence in targeting of 
lipoproteins to specific destinations. Moreover several apolipoproteins are known to 
participate in lipoprotein metabolism modulating enzymatic activity (Bolanos-Garcia & 
Miguel, 2003). 
 
1.3.1 EXCHANGEABLE APOLIPOPROTEINS 
?  Apolipoprotein AI 
Apolipoprotein AI is a single polypeptide of about 28 kDa composed of 243 amino acids 
of known sequence (Brouillette et al., 2001). There are two major sites of synthesis: the 
intestine and the liver. It is the major protein component of HDL and promotes efflux of 
phospholipid and cholesterol from cell membranes, playing a central role in reverse 
cholesterol transport (RCT) (Frank & Marcel, 2000).  
Apo AI is involved in RCT taking part to different steps: transfer of free cholesterol to 
acceptors mediated by ATP-binding cassette transporter A1 (ABCA1); esterification of 
free cholesterol to form cholesteryl esters by the HDL-associated enzyme LCAT; 
delivery of cholesterol esters to the liver mediated by scavenger receptor class B type I 
(SR-B1). Apo AI interacts with ABCA1 and accepts free cholesterol in the first step 
(Oram, 2002), acts as a cofactor for LCAT in the second one (Jonas et al., 2000) and 
mediates interaction of HDL with SR-B1 in the third one (Krieger, 1999). Moreover HDL 
and apo AI play a significant role in both modulation of endothelial function and 
inhibition of low-density lipoprotein induced monocyte chemotaxis (Barter et al., 2004). 
? Apolipoprotein AII 
Apolipoprotein AII is the second most abundant protein component of HDL and its 
major site of synthesis is the liver. In humans, apo AII is composed of two identical 
polypeptide chains, each containing 77 amino acids, connected by a single disulfide 
bridge at position 6 in the sequence (Brewer et al., 1972; Brewer et al., 1986). It has been 
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shown that apo AII is involved in HDL particles remodeling displacing apo AI from the 
surface (Lagocki & Scanu, 1980). This could result in the impairment of reverse 
cholesterol transport mediated by apo AI. Apo AII also plays a crucial role in 
triglyceride catabolism by regulating LPL activity (Julve et al., 2010). 
? Apolipoprotein AIV 
Apolipoprotein AIV is a glycoprotein containing 376 amino acid residues with a 
molecular weight of 46 kDa (Weinberg & Scanu, 1983). It is synthesized primarily in the 
enterocytes of the small intestine and it is secreted into the circulation through the 
lymphatic system. Apo AIV may facilitate and/or mediate lipid absorption, transport, 
and utilization. Its synthesis and secretion rates increase after consuming a fat-rich meal 
especially in triglyceride rich lipoproteins concomitant with a decrease in HDL 
(Kalogeris et al., 1994; Dallongeville et al., 1997). Apo AIV may participate in reverse 
cholesterol transport by activating lecithin-cholesterol acyltransferase (Steinmetz & 
Utermann, 1985) and cholesterol ester transfer protein (Main et al.1996), and facilitating 
cholesterol efflux out of cells from different tissues (Steinmetz et al., 1990).  
? Apolipoprotein CI 
Apo CI is a 57 amino acid polypeptide with a molecular weight of 6.6 kDa (Jong et al., 
1999). It is synthesized principally in the liver and has several roles in lipoprotein 
metabolism as the other members of the apolipoprotein-C family. Apo CI inhibits 
lipoprotein lipase (Berbee et al., 2005) as well as the apo E-mediated hepatic remnant 
clearance via the low-density lipoprotein receptor (LDLr) (Sehayek & Eisenberg, 1991) 
and the LDL receptor-related protein (LRP) (Weisgraber et al., 1990). These roles have 
been associated with hypertriglyceridemia. Moreover apo CI is involved in the 
modulation of the inflammatory response improving the presentation of 
lipopolysaccharide to macrophages, as revealed in vitro and in mice (Berbee et al., 
2006). 
? Apolipoprotein CII 
Apolipoprotein CII is synthesized in liver and intestine as a 79 amino acid polypeptide 
with a molecular weight of 8.8 kDa (Jong et al., 1999). Apo CII, the first apolipoprotein 
for which a specific function was found, activates LPL as a cofactor (LaRosa et al., 1970). 
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It has been shown that the helical structure close to the C-terminal end of apo CII is 
important for the activation of LPL (Shen et al, 2010). Lack of functional apo CII leads to 
hypertriglyceridemia (Breckenridge et al., 1978). 
? Apolipoprotein CIII  
Apolipoprotein CIII is synthesized in liver and intestine as a 79 amino acid protein with 
a molecular weight of 8.8 kDa (Jong et al., 1999). Apo CIII inhibits lipoprotein lipase 
activity (Wang et al., 1985) and impairs clearance of apo B lipoproteins from the 
circulation by interfering with their binding to hepatic lipoprotein receptors (Clavey et 
al., 1995), so impairing catabolism of triglyceride-rich lipoproteins. A number of studies 
demonstrates that increased plasma apo CIII concentration predicts risk for coronary 
heart disease (CHD) (Sacks et al., 2000; Scheffer et al., 2008) and that this increase is 
associated with increased levels of small, dense LDL (Shin & Krauss, 2010). Moreover, it 
has been shown that apo CIII content of apo B-containing lipoproteins enhances their 
ability to bind to the vascular proteoglycan biglycan (Olin-Lewis et al, 2002). Apart 
from its role in lipoprotein metabolism, there are evidences that apo CIII may directly 
contribute to the development of atherosclerosis by being involved in diverse 
inflammatory responses such as enhancement of human monocytic cells adhesion to 
endothelial cells (Kawakami et al., 2006). 
? Apolipoprotein E 
Apolipoprotein E is synthesized in many tissues, primarily liver, brain, skin and tissue 
macrophages. It is a glycoprotein of 299 amino acids with a molecular mass of 34 kDa 
(Mahley & Rall, 2000). Apo E is involved in normal lipoprotein metabolism, especially 
in targeting remnant lipoproteins for removal from circulation being a ligand of LDL 
receptor and LDL receptor-related protein. Moreover it has been described a role in 
reverse cholesterol transport for apo E being an activator of LCAT (Yokoyama, 1998). It 
is a polymorphic protein, and this matter influences its functional and structural 
properties. The three common allelic isoforms, apo E2, apo E3 and apo E4, differ at 
positions 112 and 158. Apo E3, the most common isoform, contains cysteine and 
arginine, respectively, whereas apo E2 has two cysteines and apo E4 has two arginines 
at these positions (Weisgraber et al., 1981). Although these isoforms differ from one 
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another by only a single amino acid substitution, the changes have profound effects at 
the structural and functional level. For example, the binding of the different isoforms to 
LDL receptors is different: apo E3 and apo E4 bind LDL receptors with similarly high 
affinity, but the binding of apo E2 is weaker (Weisgraber et al., 1982). A number of 
studies have investigated the impact of apo E polymorphisms on cardiovascular 
disease, often yielding conflicting results. Several studies link the apo E4 with greater 
risk for cardiovascular disease, while the possible relation between the apo E2 and CVD 
risk is uncertain (Kolovou et al, 2003; Eichner et al, 2002). In addition to cardiovascular 
disease, apo E polymorphisms have been investigated as a risk factor for other 
??????????????????????????????????????????????? ?????????????????????????????????????????
shown that, of the three common allelic isoforms, apo E4 confers the greatest risk of 
developing ?????? ??????????se (Farrer et al., 1997). 
? Apolipoprotein J 
Apolipoprotein J (clusterin) is a ubiquitous disulfide linked heterodimeric glycoprotein 
composed of two 40 kDa subunits (de Silva et al., 1990a). It circulates associated to high 
density lipoprotein bound to apo AI (de Silva et al., 1990b) and, in complex with apo A-
I, has cholesterol ester transfer activity (de Silva et al., 1990 a,b). Apo J is believed to 
protect cell membranes from damage and to participate in wound-repair processes 
(Rosenberg & Silkensen, 1995). It has been shown that Apo J accumulates in the artery 
wall during the development of atherosclerosis together with paraoxonase (PON) and 
Apo AI (Mackness et al., 1997). These proteins are the components of a specific HDL 
subspecies that has been implicated in the prevention of peroxidative damage. 
Moreover, it has been shown that apo J has a protective role against neointimal 
hyperplasia inhibiting VSMCs migration and restores endothelial nitric oxide synthase 
expression suppressed by TNF? (Kim et al, 2009).  
? Apolipoprotein D 
Apolipoprotein D is a protein component of human plasma lipoprotein particles, with 
maximum concentration in the high-density lipoprotein fraction. It belongs to the 
lipocalin superfamily that comprises a heterogeneous family of lipid-binding proteins, 
including fatty acid binding proteins (FABP), plasma retinol-binding proteins (RBP), 
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and apo M. In humans, apo D is a glycoprotein of 169 amino acids with an apparent 
molecular weight that varies from 19 to 32 kDa (Rassart et al., 2000). The heterogeneity 
in the apparent molecular weight has been attributed to differential glycosylation of apo 
D (Weech et al., 1986). As regard to lipoprotein metabolism, apo D contributes to 
improve triglyceride metabolism enhancing its hydrolysis and clearance (Perdomo et 
al., 2010). Moreover, it has been observed an increase in the cholesteryl esterification 
activity of LCAT in presence of apo D. This suggests a possible role for apo D in reverse 
cholesterol transport (Steyrer & Kostner, 1988). 
? Apolipoprotein M 
Apolipoprotein M (apo M) is a novel apolipoprotein belonging to the lipocalin protein 
superfamily whose members exhibit diverse properties such as lipid binding, transport, 
and immunological functions. Human apo M contains 188 amino acid residues, has a 
predicted molecular mass of 21 kDa and it is highly expressed in the liver and kidney 
(Hu et al, 2010). Human apo M contains a glycosylation site and both non-glycosylated 
and glycosylated forms of apo M are present in human plasma (Duan et al, 2001). It has 
been shown that apo M is required for HDL maturation and for cholesterol efflux to 
HDL and thereby it is implicated in the inhibition of atherosclerotic lesions formation 
(Wolfrum et al, 2005). Moreover, in healthy individuals, the plasma concentration of 
apo M was found to correlate positively with total cholesterol suggesting that apo M is 
linked to plasma cholesterol metabolism (Hu et al, 2010). 
? Serum amyloid A protein (SAA) 
SAA is a family of acute-phase proteins synthesized primarily in the liver in response to 
stimulation by cytokines. It is transported in plasma mainly associated to HDL, in 
particular to the denser subpopulation HDL3 (Coetzee et al, 1986), even though 
different studies describe an association with VLDL and LDL (King et al., 2011). During 
an acute-phase response, SAA becomes the major apolipoprotein on HDL, displacing 
apo A-I (Coetzee et al, 1986). Moreover, a number of different cell types known to have 
a role in atherogenesis have been reported to express SAA, but whether locally 
synthesized SAA may have different biological effects than systemic SAA is unclear 
(King et al, 2011). Different studies have reported that lipid-free SAA, but not SAA 
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complexed with HDL, exerts biological activity (Furlaneto & Campa, 2000; Wilson et al., 
2008).  
SAA has been shown to have proatherogenic effects, such as promotion of monocytes 
and neutrophils chemotaxis and stimulation of proinflammatory cytokines (Furlaneto & 
Campa, 2000; Badolato et al., 1994). Moreover it has been shown that overexpression of 
SAA could stimulate the synthesis of vascular proteoglycan with increased LDL-
binding affinity (Wilson et al., 2008). 
 
1.4 LIPOPROTEOMICS: STATE OF THE ART 
The knowledge of lipoprotein protein composition has been improved in the last years 
especially with the improvement of mass spectrometry (MS) technologies. Indeed, 
recent mass spectrometric studies have revealed that lipoproteins carry an array of 
proteins previously unsuspected. MS is easily linkable to gel electrophoresis and liquid 
chromatography (LC). Moreover, quantification can be realized by MS with appropriate 
labeling techniques, e.g. isotope coded affinity tags (ICAT) and isobaric tag for relative 
and absolute quantitation (iTRAQ). 
Two general approaches have evolved for protein analysis and have been applied to the 
study of apolipoproteins in VLDL, LDL and HDL: gel-based proteomics and gel-free 
proteomics (Vaisar, 2009). 
The first methodology is widely used and involves electrophoretic gel-based 
separations, primarily one-dimensional (e.g., SDS-PAGE) or two-dimensional 
electrophoresis (2-DE). 2-DE allows resolving proteins based on their isoelectric point 
(pI) in the first dimension, and on their molecular size in the second one. The resulting 
protein spots can be proteolytically or chemically cleaved into peptides that, in turn, can 
be extracted from the gel and analyzed by MS or MS/MS. 2-DE can be useful for 
quantification of relatively abundant proteins and is also a powerful tool for identifying 
different protein isoforms or studying posttranslational modifications (Görg et al, 2004); 
???? ??????? ????????? ????????? ??? ???? ??????????? ??? ?????????? ??? ??????? ????????? ?????-
?????? ?????????? ??? ????????? ????????-???? ?????????? ??? ??????-phase separation 
techniques, primarily liquid chromatography (LC), coupled with electrospray 
16 
Elisabetta Zinellu. Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis. Tesi di 
dottorato in Scienze Biomolecolari e Biotecnologiche , Università degli studi di Sassari 
ionization and tandem MS analysis (ESI-MS/MS). These techniques are powerful and 
suitable for the rapid identification of the components of complex sample mixtures and 
for the comparative quantitative analysis of the proteins contained in different samples 
(Vaisar et al, 2007). 
Before overviewing lipoproteomic studies, it is important to note that the method used 
to isolate lipoproteins significantly affects the protein content of the resulting particles. 
Traditional methods, established in the 1950s (Havel et al., 1955), imply 
ultracentrifugation in high-salt media containing KBr or NaBr. Several lipoproteomic 
studies have been published using these procedures of lipoprotein isolation (Banfi et al., 
2009; Davidson et al., 2009; Green et al., 2008; Heller et al., 2005, 2007; Hortin et al., 2006; 
Karlsson et al., 2005a, 2005b; Khovidhunkit et al., 2004; Mancone et al., 2007; Mazur et 
al., 2010; Rezaee et al., 2006; Vaisar et al., 2007, 2010; Alwaili et al, 2011). However, the 
high ionic strength and the high centrifugal field forces might cause either the 
dissociation of proteins or their exchange between different lipoprotein classes, altering 
the pattern of associated exchangeable apolipoproteins. Indeed, some of these studies 
reported a loss of proteins after a second step of ultracentrifugation (Banfi et al., 2009; 
Davidson et al., 2009; Mancone et al., 2007). Some others employed two 
ultracentrifugation procedures, using both salts and other compounds, such as sucrose 
and iodixanol (Bondarenko et al., 1999; Sun et al., 2010), reporting comparable results. 
By the way, Stahlman et al. reported that deuterium oxide (D2O) is to be preferred over 
salts at least for LDL and HDL, since for VLDL isolation, the ionic strength of the 
solution is not so relevant (Ståhlman et al., 2008). Alternatively, lipoprotein can be 
isolated by means of immunopurification methods that rely on antibodies specific for 
the dominant protein of each class (Levels et al., 2007, 2011; Ogorzalek Loo et al., 2004; 
Rashid et al., 2002; Rezaee et al., 2006). Although this procedure does not lead to loss of 
weakly associated proteins, it tends to nonspecifically co-purify associated proteins as 
serum contaminants and other lipoprotein fractions having the same antibody target 
(e.g. apolipoprotein AI is the main HDL apolipoprotein but it is also present in both 
VLDL and LDL fractions). Other lipoprotein isolation methods that have been applied 
in lipoproteomic studies, involve electrophoretic techniques, specifically free solution 
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isotachophoresis (Böttcher et al., 2000), and chromatographic techniques, such as fast 
protein liquid chromatography (Collins & Olivier, 2010; Richardson et al., 2009) and 
size exclusion/affinity chromatographies (Gordon et al., 2010). 
Several proteomic studies have been published so far on VLDL, LDL and HDL. The 
major part of these studies has been performed in healthy subjects, in the attempt to 
elucidate the apolipoprotein cargo of the lipoprotein species using different proteomic 
approaches. Conversely, only a few focused on lipoproteomics in relation to 
atherosclerosis. 
 
1.4.1 LIPOPROTEOMICS IN HEALTH 
Both 2-DE coupled to MS and gel-free MS approaches have been applied to the study of 
VLDL, LDL, and HDL protein composition in healthy subjects. These studies are 
summarized in table 1 and discussed below.  
 
? VLDL 
Mancone et al., by using 2DE coupled to MALDI TOF/TOF MS analysis, provided a 
detailed map of VLDL, isolated by the classical ultracentrifugation method, from a 
plasma pool of 3 healthy volunteers. They identified two newly VLDL associated 
proteins, namely apo LI and prenylcysteine lyase that were known to be associated with 
HDL, and some post-translational modifications of Apo E (Thr212 glycosylations) and 
apo LI (Ser296 phosphorylation) (Mancone et al., 2007). Sun et al. used two different 
analytical approaches to compare the protein content of VLDL and LDL isolated from 
pooled samples of healthy subjects by either NaBr or iodixanol gradient 
ultracentrifugation. By using a gel-free approach based on LC coupled to MS/MS 
analysis of tryptic digests labeled with iTRAQ (isobaric tag for relative and absolute 
quantitation) tags, they revealed 15 proteins differentially expressed in the two classes 
of lipoproteins. By using 2-DE coupled with LC MS/MS, they further revealed 6 
proteins differentially expressed as well. Moreover, the 5 apo AI isoforms were found to 
be phosphorylated. This study, besides describing the VLDL and LDL lipoproteomes, 
18 
Elisabetta Zinellu. Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis. Tesi di 
dottorato in Scienze Biomolecolari e Biotecnologiche , Università degli studi di Sassari 
provided insights into the metabolic changes, in terms of protein composition, during 
physiological VLDL to LDL transition (Sun et al., 2010).  
While the studies described above focused on the human lipoproteome of mature 
VLDL particles, other researches tried to shed light on VLDL assembly and maturation 
in animal models. For example, Rashid et al. immunopurified apo B from rat liver 
microsomes treated with chemical crosslinkers. Then, using LC MS/MS technology, 
they identified 99 unique proteins that co-immunoprecipitated with apo B, many of 
which were ribosomal proteins (Rashid et al., 2002). 
? LDL 
Karlsson et al. provided a 2-DE map of LDL-associated proteins from pooled plasma of 
4 healthy subjects purified by KBr density gradient ultracentrifugation. Their results 
confirmed the presence of proteins known to be associated with LDL particles, showing 
that many of these were present in different isoforms. In particular, they detected three 
proteins not previously identified in LDL: serum amyloid A-IV, calgranulin A, and 
lysozyme C. To confirm that the proteins identified were truly associated with LDL 
rather than adsorbed during the isolation procedure, LDL was also purified by size-
exclusion chromatography (Karlsson et al., 2005a). Moreover, they described three 
isoforms of apo M that were characterized for PTMs in a following work (Karlsson et 
al., 2006). Stahlman et al. applied 2DE coupled to MALDI TOF/TOF and SELDI TOF 
MS as well, to compare VLDL, LDL and HDL isolated from pooled plasma of 5 healthy 
donors by ultracentrifugation using either KBr or D2O/sucrose to generate the gradient. 
VLDL profiles obtained with the two procedure of isolation were almost identical. 
Conversely, 2-DE maps and SELDI TOF profiles of LDL and HDL were qualitatively 
similar, but differed in relative abundance of some protein species. Moreover, a reduced 
protein-lipids ratio was detected in LDL and HDL fractions purified by using KBr 
indicating that in the D2O buffer the lipoproteins retained a higher content of 
exchangeable apoproteins (Ståhlman et al., 2008). LDL-associated proteins have also 
been studied using other proteomic approaches. Banfi et al. applied liquid-phase IEF 
and 1-DE coupled with LC MS/MS to characterize the proteome of LDL isolated by 
density gradient ultracentrifugation from healthy subjects. They identified LDL-
19 
Elisabetta Zinellu. Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis. Tesi di 
dottorato in Scienze Biomolecolari e Biotecnologiche , Università degli studi di Sassari 
associated proteins not previously described, including prenylcysteine lyase (PCL1), 
orosomucoid, retinol-binding protein, and paraoxonase-1. The authors analysed PCL1 
distribution in all the lipoprotein classes isolated by ultracentrifugation from 6 healthy 
subjects showing a decline from VLDL to LDL to HDL and its absence in lipoprotein-
depleted plasma. Due to the oxidizing role of PCL1, they hypothesized that lipoproteins 
can themselves generate pro-oxidant species, thus suggesting a new role for lipoprotein 
in the development of atherosclerosis (Banfi et al., 2009). Bancells et al. analysed the 
proteome of LDL subfractions isolated by anion exchange chromatography after 
sequential ultracentrifugation of pooled healthy subjects plasma. Proteomic analysis, 
performed by LC MS/MS method, revealed the presence of 28 proteins most of which 
were involved in inflammation, coagulation and innate immunity, besides 
apolipoproteins involved in lipid metabolism. They observed that electronegative LDL, 
a minor subfraction of LDL fraction, has a higher content of minor proteins, especially 
apo F and apo J, compared to electropositive LDL (Bancells et al, 2010). Collins et al. 
performed a proteomic analysis, applying LC MS/MS, to compare the lipoprotein-
associated proteins derived from plasma and serum samples. They isolated both HDL 
and LDL from healthy subjects by means of fast protein liquid chromatography-size 
exclusion chromatography (FPLC-SEC). 16 proteins, several of which were complement 
subcomponents, were found only in the LDL fraction. 65 proteins were identified to be 
unique to HDL, while another list of proteins was found to overlap between the two 
lipoprotein fractions. Regarding the differences between plasma- and serum-derived 
LDL and HDL particles, the authors reported that the most relevant differences 
regarded fibrinogen proteins which were depleted in serum. Therefore, they stated that, 
apart from significantly higher levels of apo B100 in LDL purified from serum samples, 
comparative proteomic analysis of plasma and serum gives similar results (Collins & 
Olivier, 2010). 
? HDL 
HDL is the most studied among lipoprotein particles, probably because of its anti-
atherogenic functions. Proteomic studies in humans succeed in identifying, besides the 
known apolipoproteins involved in the lipoprotein metabolism, other associated 
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proteins such as acute-phase response proteins, proteinase inhibitors, and members of 
the complement activation. Therefore, characterizing the HDL proteome should help in 
the identification of novel anti-inflammatory and cardioprotective actions of HDL and 
could provide insights into lipid therapy. The most used among the several proteomic 
approaches that have been applied to characterize the HDL-associated proteins is 2-DE 
coupled with MS. Böttcher et al. applied two-dimensional non-denaturing gradient gel 
electrophoresis (2D-GGE) and immunoblotting to analyse HDL subfractions isolated 
from healthy subjects. By means of free solution isotachophoresis (FS-ITP), they 
separated 3 HDL subfractions, namely fast (fHDL), intermediate (iHDL) and slow-
migrating (sHDL). Proteomic analysis showed compositional differences in HDL 
subfractions. In particular, they observed that fHDL and iHDL contained the bulk of 
HDL and of apo AI. Apolipoproteins other than apo AI and apo AII were not detectable 
in fHDL, while sHDL contained several minor apolipoproteins such as apo AIV, apo D, 
apo E, apo J, and factor H. Apo CIII was found mainly in iHDL and sHDL with only 
little apo CIII in fHDL (Böttcher et al., 2000). A study performed by Ogorzalek Loo et al. 
suggests that a synergy between classical 2-D gels and virtual 2-D gels can be useful for 
studying HDL protein composition. Virtual 2-DE is based on combining a first-
dimensional isoelectric focusing (IEF) separation on polyacrylamide gels with MALDI 
MS surface scanning of the dried gel. In such a way, a virtual 2D gel can be created, 
generating an image in which mass spectrometry substitutes the second-dimension 
SDS-PAGE separation. By this approach the authors examined HDL isolated from 
human sera by selected-affinity immunosorption of apo AI and revealed 42 unique 
masses for protein species with isoelectric points between pH 5.47?5.04 (Ogorzalek Loo 
et al., 2004). Heller et al. by using multiple proteomic approaches such as native or 
denaturing PAGE coupled with LC MS/MS, shotgun LC MS/MS and MALDI TOF MS 
profiling, analysed the protein complement of HDL3, HDL2, HDL2/LDL and 
LDL/VLDL enriched fractions, isolated from a plasma pool of 10,000 healthy donors by 
density gradient ultracentrifugation. Therefore, they were able to characterize 
comprehensively the protein composition of the purified lipoprotein fractions (Heller et 
al., 2005). Karlsson et al. provided a detailed 2-DE map of HDL2 and HDL3 isolated by 
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salt gradient ultracentrifugation from pooled plasma of 4 healthy volunteers. Besides 
several isoforms of apolipoproteins already described to associate with HDL, they 
identified new proteins such as ?-1-antitrypsin, two isoforms of salivary-?-amylase in 
HDL2 and a glycosylated apo AII in HDL3 (Karlsson et al., 2005b). By using 1-DE and 
2-DE MALDI TOF MS and isotope-coded affinity tag (ICAT), Rezaee et al. detected 
many more proteins than Karlsson et al. in ultracentrifugally isolated HDL. This was 
the first study employing an ICAT method to identify lower abundance proteins. The 
overall identified proteins are known to be involved in different functions, such as lipid 
transport and metabolism, inflammation, immune system, hemostasis and thrombosis 
(Rezaee et al., 2006). The higher number of identified proteins could be ascribed to the 
use of ICAT method that improve the sensitivity of the detection as well as to the use of 
a single step of ultracentrifugation to isolate HDL.  
Besides 2-DE analyses, several groups have applied different gel-free proteomic 
approaches to characterize HDL proteome in healthy subjects. One of the first attempts 
was performed by Bondarenko et al. that used MALDI TOF MS and ESI TOF MS 
techniques to the analysis of intact protein of HDL isolated by density gradient 
ultracentrifugation in sucrose solution. They observed forty-nine peaks in the MALDI 
spectrum and 11 species in the ESI MS spectrum corresponding to the most abundant 
apolipoproteins, such as apo AI, apo AII, apo CI, apo CII, and apo CIII showing 
different isoforms due to post-translational modifications (Bondarenko et al., 2002). 
Applying immobilized pH gradient isoelectric focusing (IPG IEF) coupled with MALDI 
TOF MS, Farwig et al. were able to detect also SAA IV in HDL isolated by 
ultracentrifugation in CsBiEDTA. They developed a successful method for recovering 
the apolipoproteins from immobilized pH gradient gels prior to MALDI analysis, 
demonstrating the analytical power of linking the IPG pI profile with MALDI TOF MS 
analysis (Farwig et al., 2003). Hortin et al. focused on HDL-associated low molecular 
weight peptides. By using either HPLC-MALDI TOF MS or HPLC-ion trap mass 
spectrometry, 68 peptides in the 1-5 kDa size range were identified in ultracentrifugally 
isolated HDL. Among these, 19 were fragments derived from well-known HDL-
associated protein while others were derived from non-lipoprotein plasma proteins as 
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fibrinogen, ?1-proteinase inhibitor, and transthyretin, suggesting that HDL particles 
may represent significant reservoirs of small peptides in the circulation (Hortin et al., 
2006). Levels et al. applied SELDI TOF MS technologies to HDL isolated from 
normolipidemic individuals by means of immunocapturing directly on a SELDI protein 
chip covalently bound with anti apo AI or anti apo AII antibodies. In this way, 95 peaks 
in the 3?50 kDa molecular mass range and 27 more peaks between 50 and 160 kDa were 
detected (Levels et al., 2007). Gordon et al. applied MS-based proteomic approaches to 
the analysis of HDL purified from healthy subjects by means of gel filtration 
chromatography. To overcome problems related to nonspecific co-purification, they 
isolated only phospholipid-containing particles using calcium silicate hydrate (CSH), 
that were subjected to trypsin digestion while still bound to the CSH for identification 
by means of LC MS/MS. By this approach 47 proteins were identified. Among these, 14 
were described as newly discovered HDL-associated proteins that support roles for 
HDL in complement regulation and protease inhibition (Gordon et al., 2010). To 
investigate the role of specific subspecies in the anti-atherogenic effects of HDL, 
Davidson et al. applied LC MS/MS to investigate the distribution of associated proteins 
across 5 subpopulations of HDL from healthy human volunteers. Subjecting one set of 
samples to sequential ultracentrifugation followed by salt gradient ultracentrifugation, 
and the other one to a single step of salt gradient ultracentrifugation they identified 22 
and 28 proteins, respectively. Among them, the majority were apolipoproteins already 
known to be associated with ultracentrifugally-isolated HDL, while several 
complement factors and protease inhibitors already documented in other proteomic 
studies were not detected. By using peptide counts determined by MS, they monitored 
the relative abundance of a given protein across the HDL subfractions. Some proteins 
were found to associate preferentially to a specific subclass, while others were 
uniformly distributed across the subpopulations. This finding supports the proposal 
that HDL is composed of distinct subpopulations of particles that have discreet 
biological properties (Davidson et al., 2009). 
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Table 1. Summary of lipoproteomic studies performed in healthy subjects. Studies on 






[n° of protein isoforms] 
Ref. 
VLDL    
a pool of 3 
healthy 
volunteers 





Proteins identified:  
apo E [5], apo LI [7], apo CIV 
[3], apo AIV, apo AI, apo M, 










Two step density 
gradient 
ultracentrifugation 
with either iodixanol or 
NaBr to isolate VLDL 
and LDL 
 













apo B100, apo AII, apo AI, 
apo L1 
 
Proteins identified: apo CIII 
[3], apo CII [3], SAA [2],  
SAA IV [5], apo M [4], apo AI 
[5], apo D [4], apo E [6], apo J 
[3], apo LI [7], apo AIV [3], 
paraoxonase 1 [2], ?-1-
antitrypsin [2], 
prenylcysteine oxidase 1 [5],  
and albumin [2] 
Sun et al., 
2007 
microsomes 
prepared from rat 
liver 
solubilized proteins were 
coimmunoprecipitated 




99 unique proteins many of 
which were ribosomal proteins. 
Moreover many hepatic 
enzymes, some known 
chaperone proteins and ferritin 




LDL    











Proteins identified: apo B100, 
apo CII, apo CIII [3], apo E 
[4], apo AI [2], apo AIV, apo J 
and apo M [3], SAA IV [2], 





Elisabetta Zinellu. Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis. Tesi di 
dottorato in Scienze Biomolecolari e Biotecnologiche , Università degli studi di Sassari 
plasma pool from 






2DE MALDI TOF/TOF 
and SELDI-TOF-MS 
WB 
Proteins identified: ?1 anti-
trypsin, apo J, apo E, apo AI, 










liquid phase IEF, PAGE 
and LC-ESI-MS/MS. 
WB 
Proteins identified: apo M, 
apo D, paraoxonase 1, apo 
AI, apo B100, apo AIV, apo E, 
apo J,  apo H, SAA, 
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fractionate LDL into 







28 proteins identified in both 
fractions: proteins belonging 
to the apolipoprotein families 

















16 newly identified proteins 















Apo AI ,apo AII, apo AIV, 
apo E, apo D, apo CIII, apo J, 












49 peaks in the MALDI 
spectrum 
11 species in the ESI 
spectrum 
corresponding to different 
isoform of 
apo AI, apo AII, apo CI, apo 
CII, and apo CIII 
Bondaren
ko et al., 
2002. 
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MALDI TOF MS 
apo AI, apo AII, apo CI, apo 
CII, apo CIII and SAA IV 
Farwig et 
al., 2003 





42 unique masses for protein 
species with isoelectric points 
between pH 5.47-5.04 
Ogorzale
k Loo et 
al., 2004 
human plasma 
pool of more than 
10 000 donors 
salt gradient 
ultracentrifugation 
pooling of lipoprotein 




Native/SDS, 2D PAGE 
and LC-MS/MS; 







antitrypsin, apo A-I, 
???????????????????????????-
2-HS glycoprotein, vitamin 
D-??????????????????-1 acid 
glycoprotein, paraoxonase, 
apo AIV, apo L, apo J, 
haptoglobin related protein, 
apo D, galectin 7, apo E, apo 
F, serum amyloid A 4, apo 
AII, apo CI, apo CIII, aortic 
smooth muscle actin, apo CII, 




obtained from a 
pool of four 
healthy 
volunteers 
HDL2 and HDL3, were 





apo AI [6], apo AII, apo AIV, 
apo CI, apo CII, apo CIII [2], 
apo E [5], apo M [2], SAA [2], 
and SAA-IV [6], ?-1-
antitrypsin, salivary ?-
amylase, apo L and a 





400 mL of blood 
freshly collected 
from a healthy 
donor 
KBr density gradient 





HPLC-ion trap MS 
more than 100 peptide 
components were found in 
the size range from 1000 to 
5000 Da 
19 peptides derived from 
HDL-associated proteins; 49 
peptides of proteins not 
considered to be components 
of HDL (fibrinogen, 
?????????????????-proteinase 
??????????????-glycoprotein, 
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normal healthy 
volunteers 
one-step salt gradient 
ultracentrifugation 
 
1-DE and 2-DE 





Proteins identified: 56 HDL-
associated proteins including 
all known apolipoproteins, 
proteins involved in 
hemostasis and thrombosis 
and proteins of the immune 
and complement system. 
Furthermore, growth factors, 
receptors and hormone-










95 peaks were detected in the 
3?50 kDa molecular mass 
range. Between 50 and 160 















Proteins identified: ?1 anti-
trypsin, apo E, apo -I, SAA 




































22 proteins from pooled 
samples were identified: apo 
AI, apo B, apo E, apo AII, apo 
M, SAA IV, apo CI, apo D, 
apo CIII, apo L1, apo CII, 
SAA (1 and 2), apo F, PON1, 
apo C-IV, PLTP, PAF AH IB, 
apo(a), apo J, PON 3, ?1 anti-
trypsin, apo A-IV. 
 
6 more proteins from 
individual donors were 
identified: 
?????????????????????????????
haptoglobin related protein, 
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Proteins identified: 47. 
14 of them were described for 
the first time as HDL 
associated protein: 
complement factor B, heparin 
cofactor 2, Ig lambda chain C 
regions, complement C5 
precursor, pigment 
epithelium-?????????????????-
1- antichymotrypsin, insulin 
like growth factor binding 
protein acid labile subunit, 
antithrombin III, kallistatin, 
lumican precursor, plasma 
protease CI inhibitor, 



















1.4.2 LIPOPROTEOMICS IN RELATION TO ATHEROSCLEROSIS 
Only few studies have been published on the study of VLDL, LDL, and HDL protein 
composition in relation to atherosclerosis. These studies are discussed in detail below 
and summarized in table 2.  
? VLDL 
Bondarenko et al. applied MALDI TOF and ESI TOF MS techniques to identify low 
molecular weight proteins constituting VLDL from 3 healthy subjects and 1 
hyperlipidemic subject without previous tryptic digestion. By this approach they 
identified 15 apo C isoforms and 1 apo E isoform and observed higher level of apo CIII 
in the hyperlipidemic subject (Bondarenko et al., 1999).  
? LDL 
Up to date, only few studies on LDL proteomics and atherosclerosis have been 
reported. 2DE coupled with LC MS/MS and label-free quantitative MS (LFQMS) was 
applied by Richardson et al. to the analysis of LDL in the early stages of atherosclerosis 
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in an animal model. LDL was isolated by fast protein LC (FPLC) from non-diabetic 
hyperlipidemic, diabetic dyslipidemic, diabetic dyslipidemic under exercise training, 
and healthy Yucatan pigs (Richardson et al., 2009). They identified 28 unique proteins 
and detected several differential expression patterns for apo E, AI, CIII, fibrinogen, apo 
B, adiponectin, alpha-2-macroglobulin, complement C1q, ficolin, and apo J. Since LDL 
was isolated from pigs in the early stages of atherosclerosis, the alterations observed 
might be involved in the initiating stages of the disease. LDL-associated proteins have 
also been studied using other proteomic approaches. For example Davidsson et al. 
applied SELDI TOF technologies to compare LDL associated proteins from 
atherosclerotic patients (having either metabolic syndrome or diabetes) to that from 
healthy subjects. They focused on small dense LDL isolated by means of gradient 
ultracentrifugation using D2O. The results showed that LDL from patients had lower 
content of apo AI, apo CI and apo E and higher content of apo CIII, the latter 
responsible for higher affinity for arterial proteoglycans that could facilitate LDL in situ 
oxidative modifications (Davidsson et al., 2005). 
? HDL 
A limited number of studies have focused on HDL proteomes in relation to 
atherosclerosis. 
Khovidhunkit et al. investigated changes in proteins associated to HDL during 
inflammation by means of 2-DE and LC MS/MS in an animal model. For this purpose, 
they analysed HDL isolated by salt gradient ultracentrifugation from sera of mice 
injected with normal saline or with endotoxin so detecting increased levels of SAA, apo 
E, apo AIV and apo AV and decreased levels of apo AI and apo AII in acute-phase HDL 
(Khovidhunkit et al., 2004). Vaisar et al. used a shotgun LC MS/MS approach to 
identify proteins associated to total plasma HDL isolated from 20 healthy individuals. 
In this way, they described 48 proteins, 13 of which not yet known to associate to HDL. 
Moreover, they compared plasma HDL3 fraction isolated from 6 healthy donors and 7 
CAD patients. By means of Gene Ontology (GO) Consortium analysis, they were able to 
associate the array of HDL proteins to biological processes. Members of the 
complement pathway and endopeptidase inhibitors were found, suggesting that HDL 
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plays also roles in regulating the complement system and protecting tissue from 
proteolysis. Thereafter, they found that some proteins associated to HDL3 were 
upregulated in CAD patients, in particular apo CIV, PON1, complement C3, apo AIV, 
and apo E. Interestingly, they found three of these proteins also in HDL isolated from 
human carotid atherosclerotic tissues, being apo E the most abundant (Vaisar et al., 
2007). In another study, they investigated whether combined statin and niacin therapy, 
which increase HDL cholesterol levels and reduce CAD risk, could reverse the changes 
in the protein composition observed in HDL3. For this purpose HDL3, isolated from 6 
CAD patients before and 1 year after combined therapy, were subjected to LC?Fourier 
Transform Ion Cyclotron Resonance MS. By means of spectral counting and extracted 
ion chromatograms they found that treatment decreased apo E levels and increased apo 
J, apo F, and phospholipid transfer protein levels (Green et al., 2008). In a following 
study, they investigated if protein composition was altered in HDL2 isolated from CAD 
patients. Ultracentrifugally isolated HDL2 was digested with trypsin and analysed by 
MALDI TOF MS and pattern recognition analysis. The most significant informative 
features were then subjected to LC MALDI MS/MS for identification. This analysis 
revealed that HDL2 of CAD subjects carried a distinct protein cargo with increased 
levels of apo CIII and decreased levels of apo CI, two apolipoproteins involved in the 
metabolism of HDL particles. Moreover, they found increased levels of apo AI peptides 
containing oxidized methionine indicating the occurence of oxidative processes in CAD 
patients (Vaisar et al., 2010). Heller et al. used a shotgun LC MS/MS approach to 
characterize HDL protein composition of 7 hypercholesterolemic subjects and 9 
normolipidemic ones. They used the peptide match score summation index, based on 
probabilistic peptide scores for absolute protein quantitation. By this approach, they 
found that in hypercholesterolemic subjects apo AI levels were reduced while apo CI, 
apo CIII, and apo E levels were increased, suggesting that HDL protein composition 
could be altered in lipemic disease (Heller et al., 2007). Mazur et al. applied differential 
top-down mass spectrometry to compare HDL3 protein profiles between 3 subjects 
having low HDL cholesterol and 3 subjects having high HDL cholesterol. Differently 
????????????????????????????????????????????????????????????????????????????????????
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proteins into short peptid???? ????-?????? ?????????? ??????????? ????????????? ???????
proteins. In this study HDL3 samples were analysed by a reverse-phase nano-HPLC 
coupled to a linear trap quadrupole Fourier transform (LTQ-FT) hybrid mass 
spectrometer. The authors found 380 peaks that changed significantly in protein 
abundance between high HDL-c and low HDL-c subject groups demonstrating that this 
approach is suitable for the detection of quantitative differences in proteins and protein 
isoforms in human HDL samples (Mazur et al., 2010). Very recently, Levels et al., 
applied SELDI TOF MS to HDL isolated, by apo AI immunocapturing, from healthy 
subjects having low HDL-c and high HDL-c challenged with an endotoxin for 24 hours. 
Overall they observed profound changes in 21 markers in both study groups proteome 
independently from HDL cholesterol levels (Levels et al., 2011). Alwaili et al. applied 1-
D followed by LC-MS/MS to HDL isolated by sequential ultracentrifugation from male 
control, stable CAD, and ACS subjects (n=10/group). They identified 67 HDL-
associated proteins involved in lipid binding, acute-phase response, immune response, 
and endopeptidase/protease inhibition. By means of spectral counting they found that 
nine proteins were differently abundant, three of which were confirmed by western 
blotting and ELISA: levels of apo AIV were found to be significantly reduced, whereas 
levels of serum amyloid A and complement C3 were significantly increased in ACS 
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Table 2. Summary of lipoproteomic studies performed in relation to atherosclerosis. 
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2 AIM OF THE STUDY 
Lipoproteins have attracted a great deal of interest because of their implication in the 
development of cardiovascular diseases, such as atherosclerosis. It is well known that 
high levels of LDL cholesterol and low levels of HDL cholesterol strongly associate with 
an increased risk of developing atherosclerosis. Moreover, clinical studies suggest that 
levels of apo B100 and apo AI, may be better predictors (Walldius et al., 2001). Since the 
protein component of these particles is largely responsible for carrying out their various 
functions, obtaining detailed information about the apolipoprotein composition and 
structure may contribute to reveal their role in atherogenesis and to identify new 
biomarkers of the pathology. The identification of new biomarkers could be useful in 
diagnosis and could improve the therapeutic approaches adopted for the treatment of 
lipoprotein-associated disorders. Applying proteomics to the study of lipoproteins 
seems to contribute significantly to the achievement of this goal. Indeed, in the last 
decade several proteomic approaches have been applied to the study of lipoprotein-
associated proteins showing that lipoproteins carry an array of proteins previously 
unsuspected. The majority of these studies have been performed on healthy subjects, 
while only few studies have tried to shed light on the apolipoprotein composition in 
relation to atherosclerosis. 
Therefore, the aim of this study was to characterize the apolipoprotein component of 
plasma lipoproteins isolated from atherosclerotic patients undergoing carotid 
endarterectomy and to identify differentially expressed apolipoproteins between 
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3 MATERIALS AND METHODS 
3.1 SAMPLE COLLECTION 
Analyses were performed on 4 pooled plasma samples from 57 healthy volunteers and 
79 patients undergoing carotid endarterectomy ?????????? ?? ????. All patients were 
under pharmacological treatment for both hypertension and dyslipidemia. The main 
clinical parameters of patients are reported in table 3. Blood samples were collected 
after an overnight fast into Vacutainer tubes containing EDTA and immediately 
processed. After centrifugation at 2000 x g for 10 min at 4°C, plasma was separated and 
stored at -80°C until analysis. 
 
Table 3. Main clinical parameters of the patients undergoing carotid endarterectomy 
analysed in this study. 
Clinical parameters Patients (79) 
Age, y  69.2 ± 7.2  
Sex ratio, m/f  48/31 
Body mass index, kg/m2  26.3 ± 3.9 
Symptomatic, %  40.0 
Transient ischemic attack, %  28.6 
Ictus, % 71.4 
Diabetes, % 30.6 
Hypertension, %  87.8 
Dyslipidemic, %  83.7 
Triglycerides, mg/dL  123.9 ± 53.2 
Total cholesterol, mg/dL  172.1 ± 43.4 
LDL cholesterol, mg/dL  97.4 ± 37.8 
HDL cholesterol, mg/dL 47.3 ± 13.4 
Values are mean ± SD 
  
 
3.2 LIPOPROTEINS PURIFICATION 
Lipoproteins were isolated by isopycnic ultracentrifugation according to the methods 
described by Himber et al. (Himber et al, 1995) and McDowell et al. (McDowell et al, 
1995) with slight modifications (figure 3). Briefly, 3.9 mL of pooled plasma samples was 
added with NaBr (d=1.3 g/mL) in centrifuge tubes (Beckman, Ultraclear 14 x 95 mm), 
overlaid with 8.1 mL of 150 mM NaCl and centrifuged at 285000 x g for 48 h at 4°C in a 
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Optima L90 series ultracentrifuge equipped with a SW40 Ti rotor (Beckman Coulter). To 
avoid contamination, lipoprotein fractions were then further purified by a second 
centrifugation step. VLDL, LDL and HDL fractions were floated in saline solutions at 
density 1.006, 1.063 and 1.21 g/mL, respectively, and were centrifuged under the same 




Figure 3. Lipoproteins purification method adopted in this study. 
 
Lipoprotein fractions were then collected, desalted and concentrated using centrifugal 
filter units (10 KDa MWCO, Millipore). Protein concentrations were determined with a 
DC Protein Assay Kit (Bio-???????????????????????? ?????????? ??? ???????????????????
instructions, using bovine serum albumin as a standard. Al????????????????????????????
???? ??? ??? ????? ????? ???????????? ??? ??????? ???-cold tri-n-
butylphosphate:acetone:methanol (1:12:1). 
Precipitates were subjected to repeated boiling and sonication passages in 4% CHAPS, 
10 mM TRIS, 1% DTT solution, cooled to room temperature, and added with 8M UREA, 
4% CHAPS, 1% DTT, 0.4% CA solution for further solubilization followed by two-
dimensional electrophoresis ?????????? ??? ??? ??? ???-delipidated HDL were treated as 
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3.3 2-DE ANALYSIS 
Two-dimensional electrophoresis was conducted as previously described (Lepedda et 
al, 2009). Briefly, samples were applied to 70 mm IPG strips (pH 4?7, Bio-Rad, Hercules, 
CA, USA) by overnight rehydration loading at 20°C and subsequently focused at 50 
????PG strip for 22 kVh at 20°C. 
After focusing, proteins were in-gel reduced (1% (w/v) DTT) and alkylated (2.5% (w/v) 
iodoacetamide), under continuous shaking, prior to the second dimension. The IPG 
strips were then sealed with 0.5% low melting point agarose in SDS running buffer at 
the top of slab gels (8 cm x 7 cm x 0.1 cm). SDS?PAGE was carried out, using 15%T, 
3%C polyacrylamide gels, at 50V for 15 minutes and subsequently at 150V for about 90 
minutes. Gels were stained with Mass Compatible Super Blue Stain Kit (Nurex srl, 
Sassari) and scanned at ????? ??? ??????????? ?????? ?? ??-800 densitometer (Bio-Rad, 
Hercules, CA, USA). Image analyses were performed using the PD Quest 2-D analysis 
software V 8.0.1 (Bio-Rad, Hercules, CA, USA). 
 
3.4 IN-GEL DIGESTION AND MALDI-TOF MS ANALYSIS 
Spots of interest were excised with sterile ???????? ????? ??????????????????? ?????????? ??
mM NH4HCO3/50% acetonitrile. Gel pieces were then dehydrated with acetonitrile, 
dried at room temperature and reswollen with 5 mM NH4HCO3 solution containing 10 
????????????????????? ??utes on ice. Tryptic digestion was conducted overnight at 37°C. 
Then, the obtained peptides were mixed with an equal volume of ?-cyano-4-
hydroxycinnamic acid saturated solution (40% (v/v) acetonitrile, 0.1% (v/v) 
trifluoroacetic acid) and applied as a microcrystalline thin film onto a 96-spot MALDI 
target. Mass analyses were performed using a MALDI micro MX Mass Spectrometer 
(Waters). Peptide masses (plus one H+) were submitted to database (NCBI and Swiss-
Prot) search by using Mascot or Profound as search engines. Restrictions were Homo 
sapiens, 50?100 ppm mass deviation, maximum one missed cleavage by trypsin, and 
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3.5 WESTERN BLOTTING ANALYSIS 
Western blotting was applied to compare expression of selected HDL proteins between 
patients and controls. Proteins were resolved by both mono-dimensional and bi-
dimensional electrophoresis. After SDS?PAGE in 15%T, 3%C gels, electroblotting was 
performed at 350 mA for 1 hour 30 minutes onto PVDF membranes (GE Healthcare, 
UK). After transfer, membranes were blocked for 1 hour at room temperature with PBS-
Tween-20 (0.1% Tween-20 in PBS) containing 3% non-fat dry milk and incubated 
overnight at 4 °C with the primary antibodies diluted in the same blocking buffer. The 
primary antibodies used were the following: goat polyclonal anti-apo AI antibody 
(Millipore), goat polyclonal anti-apo AII antibody (Millipore), mouse monoclonal anti-
apo CI antibody (Abnova), rabbit polyclonal anti-apo CII antibody (Calbiochem), goat 
polyclonal anti-apo CIII antibody (Millipore), rabbit polyclonal anti-apo D antibody 
(Sigma-Aldrich), goat polyclonal anti-apo E antibody (Millipore), mouse monoclonal 
anti-SAA antibody (Abcam), goat polyclonal anti-apo B100 antibody (Chemicon). Then, 
membranes were washed with PBS-Tween-20 and incubated for 1 hour at room 
temperature with the (horseradish peroxidase) HRP-conjugated secondary antibodies 
diluted 1:5000 in blocking buffer (goat anti-mouse-HRP conjugate, Bio Rad; goat anti-
rabbit-HRP conjugate, Bio Rad; rabbit anti-goat-HRP conjugate, Millipore). After 
membrane washing, proteins were visualized by ECL (Immun-Star western 
Chemiluminescent kit) followed by Q-One 4.6.3 software densitometric analysis (Bio-
Rad Hercules, CA, USA).  
A schematic workflow of the proteomic approach adopted is reported in figure 4. 
38 
Elisabetta Zinellu. Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis. Tesi di 
dottorato in Scienze Biomolecolari e Biotecnologiche , Università degli studi di Sassari 
 
Figure 4. Schematic workflow of the proteomic approach adopted. 
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4 RESULTS 
4.1 2-DE ANALYSIS 
Two-dimensional electrophoresis combined with mass spectrometry was applied to 
identify VLDL, LDL and HDL apolipoproteins from patients undergoing carotid 
endarterectomy and healthy normolipidemic control subjects. Since the apo B100 is the 
major apolipoprotein of both LDL and VLDL, large amounts of LDL and VLDL were 
processed in order to maximize detection and identification of less abundant 
apolipoproteins.  
Reproducible 2-DE maps were obtained from VLDL, LDL and HDL (figure 5, panels a-
c). Moreover, by single spin and an additional washing step, we obtained a high degree 
of purification of all lipoprotein fractions (figure 5, panels a-c). This is evident 
considering that serum albumin, the most abundant plasma protein (about 50-60% of 
total) (fig. 5, panel d), is not detectable in any of 2-D gels after coomassie brilliant blue 
G-250 staining. Moreover, the lipoproteins purification method adopted allowed us to 
obtain HDL fractions without contaminants of VLDL/LDL origin, as shown by 1-DE 
western blotting using anti apo B100 antibody (figure 6).  
By peptide mass fingerprinting (PMF), 21 spots corresponding to about 96% of 52 
protein spots detected in VLDL, 22 spots corresponding to about 92% of 43 spots in LDL 
and 20 spots corresponding to about 96% of 60 spots in HDL were identified. All the 
identified proteins, their theoretical isoelectric point (pI) and molecular weight (Mr), the 
percentage of sequence coverage and some of known functions are listed in table 4. The 
sequence coverage ranged from 22% for Apo D to 61% for SAA. 
The identified spots in both VLDL and LDL correspond to 2 isoforms of Apo J, 2 
isoforms of Apo AIV, 5 isoforms of Apo E, 6 of Apo AI, 3 of Apo D, 2 of SAA, 1 of Apo 
CII and 2 of Apo CIII. Regarding to HDL, 3 isoforms of Apo E, 6 of Apo AI, 3 of Apo D, 
2 of SAA, 1 of Apo CII and 2 of Apo CIII were identified. 
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Figure 5. 2-DE representative maps of VLDL (panel a), LDL (panel b), HDL (panel c) 
and plasma (panel d). 
 
Table 4. All the identified proteins, their theoretical isoelectric point (pI) and molecular 
weight (Mr), the percentage of sequence coverage and the differences in relative 
abundances obtained following image analysis are reported. 






Cov. (%)  HDL LDL VLDL 
2 APO J gi|178855| 6,3 48772 26       
2 APO AIV gi|178759| 5,2 45335 33 
  
? 
5 APO E gi|178853| 5,6 36185 31 
 
? 
 6 APO AI gi|90108664| 5,3 28061 33 
 
? ? 
3 APO D gi|4502163| 5,1 21275 22 
 
? ? 
2 SAA gi|225986| 5,9 11682 61 
 
? ? 
1 APO CII gi|32130518| 4,7 11284 29 
   2 APO CIII gi|4557323| 5,2 10852 36 ? 
  ??????????????????????????? 
       ?????????????????????????? 
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Figure 6. 1-DE western blotting of VLDL, LDL, HDL and plasma probed with anti- apo 
B100 antibody showing the purity of HDL fractions. 
 
Image analysis revealed differences in the relative abundance of some identified 
apolipoproteins between patients having a carotid plaque and healthy subjects (table 4, 
figures 7-9). Relative abundances higher than two fold or lower than 0.5 fold, in patients 
compared to controls, were considered to be relevant. In particular, VLDL from patients 
presented higher levels of SAA and apo E, and lower levels of Apo AIV, Apo AI and 
Apo D while LDL displayed higher levels of Apo E, Apo D and SAA. Conversely, HDL 
showed quite similar apolipoprotein profiles between patients and controls apart from 
lower levels of Apo CIII in the former.  
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Figure 7. Relative abundances of the identified apolipoproteins in VLDL from both 
patients and controls. Differentially expressed proteins are evidenced by the arrows. 
 
 
Figure 8. Relative abundances of the identified apolipoproteins in LDL from both 
patients and controls. Differentially expressed proteins are evidenced by the arrows. 
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Figure 9. Relative abundances of the identified apolipoproteins in HDL from both 
patients and controls. Differentially expressed proteins are evidenced by the arrows. 
 
4.2 WESTERN BLOTTING ANALYSIS 
4.2.1 1-DE  
 
1-DE western blotting analysis was performed on HDL fractions purified from 4 pools 
of patients who underwent carotid endarterectomy and from 4 pools of controls (figure 
10). The image analysis revealed some differences (figure 11). Levels higher than 2 fold 
or lower than 0.5 fold in patients compared to controls were considered to be relevant. 
In particular, apo CII and SAA levels were higher (3 and 2.5 fold, respectively) while 
apo CI levels were lower (0.5 fold) in patients. It is worth noting that apo AI levels were 
superimposable in the two groups of sample. This is in agreement with the differential 
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Figure 10. 1-DE western blotting of purified HDL probed with several anti-
apolipoproteins antibody. The quantity of HDL loaded in the gel differed for each 
antibody depending on their sensitivity (0.3 µg for apo AI, 0.5 µg for apo AII, 4.5 µg for 
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Figure 11. 1-DE western blotting image analysis showing different apolipoproteins 
profiles in patients. Differentially expressed proteins are reported in red. 
 
4.2.2 2-DE 
Preliminary results by 2-DE western blotting analysis performed on one HDL pool from 
patients and one HDL pool from controls showed that SAA and apo CII levels were 
higher in patients (figure 12), so partially confirming 1-DE western blotting results. The 
images regarding the 2-DE western blotting of non-differentially expressed HDL 
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Figure 12. 2-DE western blotting of differentially expressed proteins in patients 
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Figure 13. 2-DE western blotting of non-differentially expressed apolipoproteins. 10 µg 
of total HDL proteins were loaded for apo AI, 20 µg for apo AII, apo E and apo D and 
50 µg for apo CI. 
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5 DISCUSSION 
Atherosclerosis is a progressive disease of multifactorial etiology, which involves the 
interaction between genetic and environmental factors. Extensive epidemiological 
studies have shown that LDL cholesterol levels are directly related to the risk of 
developing atherosclerosis, whereas HDL cholesterol levels are inversely related to this 
risk. Since the protein component of lipoproteins is largely responsible for carrying out 
their various functions, obtaining detailed information about the apolipoprotein 
composition and structure may contribute to reveal their role in atherogenesis. For this 
purpose we purified plasma VLDL, LDL, and HDL fractions from 4 pooled plasma 
samples from 79 patients undergoing carotid endarterectomy and from 57 healthy 
volunteers by single isopycnic salt density gradient ultracentrifugation, followed by a 
second step of ultracentrifugation. This purification method allowed us to obtain highly 
purified lipoprotein fractions free of the major plasma contaminants such as albumin. 
Contamination of HDL by the other lipoprotein fractions was also excluded by western 
blotting analysis using a polyclonal anti apo B100 antibody.  
By means of 2-DE followed by PMF several lipoprotein associated proteins were 
identified in VLDL, LDL, and HDL. All of them were already known to associate with 
lipoproteins. Image analysis has revealed that some of the identified proteins differed in 
relative abundance between patients and healthy subjects. In particular, VLDL from 
patients presented higher levels of SAA and apo E, and lower levels of apo AIV, apo AI 
and apo D. LDL displayed higher levels of apo E, apo D and SAA in patients. 
As regard to HDL, 2-DE followed by PMF analysis showed quite similar apolipoprotein 
profiles between patients and controls apart from lower levels of Apo CIII in the 
former. Conversely, 1-DE and 2-DE western blotting analyses, performed only on HDL 
fraction, revealed some other differences. In particular, 1-DE analysis showed higher 
levels of apo CII and SAA and lower levels of apo CI in patients, while 2-DE confirmed 
1-DE results for apo CII and SAA. It is worth noting that some of the above mentioned 
differences were in common to the various lipoprotein fractions analysed. In particular, 
higher levels of SAA in VLDL, LDL and HDL of patients were observed. 
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SAA is known as a positive acute-phase protein transported in plasma mainly 
associated to HDL even though different studies describe an association with VLDL 
and LDL as well (King et al, 2011). During an acute-phase reaction SAA plasma 
concentration can increase by up to 100- 1000-fold over the basal level (Uhlar & 
Whitehead, 1999) and becomes the major apolipoprotein on HDL displacing apo A-I 
(Coetzee et al, 1986). The presence of SAA on HDL reduces the affinity of this 
lipoprotein for hepatocytes but increases the affinity for macrophages (Kisilevsky & 
Subrahmanyan) redirecting the clearing of HDL from the liver towards macrophages, 
which has been postulated to lead to a functional change from anti-atherogenic/anti-
inflammatory HDL particles, to pro-atherogenic HDL. Several epidemiological data 
associate CVD risk with elevated levels of SAA (Johnson et al, 2004; Schillinger et al, 
2005) raising the question whether elevated plasma level of SAA is a consequence of 
inflammation or it has a direct effect on atherogenesis. In this regard SAA has been 
shown to have pro-atherogenic effects promoting monocytes and neutrophils 
chemotaxis and stimulating pro-inflammatory cytokines expression (Furlaneto & 
Campa, 2000; Badolato et al., 1994) thus contributing to the progression of 
atherosclerosis. Moreover it has been shown that overexpression of SAA could 
stimulate the synthesis of vascular proteoglycan with increased LDL-binding affinity 
(Wilson et al., 2008). Anyway, further studies are needed to answer the question 
whether elevated levels of SAA could play a causal role in atherosclerosis.  
Another interesting result is the difference observed in the relative abundance of apo E 
between patients and controls in both VLDL and LDL. Apo E is involved in normal 
lipoprotein metabolism, especially in targeting remnant lipoproteins for removal from 
circulation being a ligand of LDL receptor and LDL receptor-related protein (Mahley & 
Rall, 2000). Apo E also influences the metabolism of lipoproteins in ways unrelated to 
its role as a ligand for receptors. The accumulation of apo E on the surface of 
lipoproteins slows the rate of lipolysis of lipoprotein triglycerides (Huang et al, 1998a; 
Huang et al, 1998b). Apo E can also affect plasma VLDL levels directly, regulating its 
synthesis and secretion (Huang et al, 1999). Generally, it is considered that apo E 
protects against the risk of developing atherosclerosis due to its role in targeting 
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remnant lipoproteins for removal from circulation. In contrast, apo E can, under certain 
conditions, increase atherosclerosis risk due to its role in inhibiting lipolysis or 
increasing VLDL production. Indeed, there is a strong body of evidence indicating that 
hypertriglyceridemia is an independent risk factor for atherosclerosis (Boullart et al., 
2011; Sarwar et al., 2007).  
Moreover, several studies linked the apo E4 isoform with greater risk for cardiovascular 
disease, even though in this regard results are often conflicting (Kolovou et al, 2003; 
Eichner et al, 2002). The higher apo E levels observed in both VLDL and LDL from 
patients could be related to the association of apo E with cardiovascular risk and raise 
the question about the isoform involved. Therefore it could be interesting to further 
investigate about this finding. 
Overall, in this study different apolipoprotein profiles have been observed in VLDL, 
LDL and HDL of atherosclerotic patients undergoing carotid endarterectomy compared 
to healthy controls. Since only few proteomic studies on the apolipoprotein composition 
in relation to atherosclerosis have been performed, this study provides useful 
information on this topic. In the future it would be auspicable to analyze also 
atherosclerotic specimens of these patients in order to evaluate differences, if any, in 
apolipoprotein profiles between circulating and plaque retained lipoproteins. Indeed, 
improving the knowledge on apolipoprotein composition and structure may help in 
revealing the role of lipoproteins in atherogenesis. Moreover the identification of new 
biomarkers could be useful in diagnosis and could improve the therapeutic approaches 
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6 SUMMARY 
Atherosclerosis is a chronic inflammatory condition characterized by the accumulation 
of lipids and fibrous elements in the large arteries. The earliest and presumably 
initiating event in atherogenesis is the selective retention of circulating apo B100 
containing lipoproteins, particularly LDL and Lp(a), in the subendothelial space, by 
means of specific interactions with artery wall proteoglycans.  
Once retained, lipoproteins are more susceptible to oxidative and enzymatic 
modifications and induce a series of biological responses that lead to atherosclerotic 
lesion formation. These responses are: endothelial alterations, recruitment of 
macrophages and lymphocytes to the intima which in turn induces an inflammatory 
state in the arterial wall, accumulation of cholesteryl fatty acyl esters in macrophages 
(so-??????? ???????????? ?????????? and migration of smooth muscle cells that produce a 
fibrous cap of extracellular matrix over the lesion. The etiology of atherosclerosis is very 
complex and includes several important environmental and genetic risk factors. In this 
regard elevated plasma levels of LDL cholesterol and low levels of HDL cholesterol 
have been long associated with the onset and development of atherosclerotic lesions.  
Lipoproteins are sopramolecular complexes consisting of hydrophobic molecules, 
particularly triacylglycerol and cholesteryl esters, stabilized with a coat of amphipathic 
compounds: phospholipids, unesterified cholesterol and proteins, referred to as 
apolipoproteins. The common function of all apolipoproteins is to help solubilize 
neutral lipids in the circulation but they have also roles in receptor recognition and 
hence in targeting of lipoproteins to specific destinations. Moreover several 
apolipoproteins are known to participate in lipoprotein metabolism modulating 
enzymatic activity. Therefore, obtaining detailed information about their composition 
and structure may contribute to reveal their role in atherogenesis and to identify new 
biomarkers of the pathology that could be useful in diagnosis and in improving the 
therapeutic approaches adopted for the treatment of atherosclerosis. The knowledge of 
lipoprotein protein composition has been improved in the last years especially with the 
improvement of proteomics technologies. Anyway, the majority of the lipoproteomic 
studies existing in literature are directed to the characterization of the lipoprotein 
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protein composition in healthy subjects, while few studies exist in relation to 
atherosclerosis. In this regard the aim of this study was to characterize the 
apolipoprotein component of plasma lipoproteins isolated from atherosclerotic patients 
undergoing carotid endarterectomy and to identify differentially expressed 
apolipoproteins between patients and controls. By means of 2-DE followed by peptide 
mass fingerprinting several lipoprotein associated proteins were identified in VLDL, 
LDL, and HDL. The analysis of both 2-DE maps and 1-DE and 2-DE western blotting 
has revealed different apolipoprotein profiles in the three lipoprotein fractions. In 
particular higher levels of SAA in VLDL, LDL and HDL from patients and higher levels 
of apo E in both VLDL and LDL from patients were observed. Several epidemiological 
data associate elevated levels of SAA with the risk of developing cardiovascular 
diseases. Moreover, it has been shown that SAA could have pro-atherogenic effects 
promoting both LDL retention and inflammation. Anyway, further studies are needed 
to answer the question whether elevated levels of SAA could play a causal role. As 
regard to apo E, it is considered protective against the risk of developing atherosclerosis 
due to its role in targeting remnant lipoproteins for removal from circulation being a 
ligand of LDL receptor and LDL receptor-related protein. Anyway, it has been shown 
that, under certain conditions, apo E can increase the risk of atherosclerosis due to its 
role in inhibiting lipolysis or increasing VLDL production. Moreover, several studies 
linked the apo E4 isoform with greater risk for cardiovascular disease. Overall, in this 
study different apolipoprotein profiles have been observed in VLDL, LDL and HDL of 
atherosclerotic patients compared to controls. More studies have to be done in the 
future not only to confirm the results obtained for apolipoproteins profiles of 
circulating lipoproteins, but also to analyse the atherosclerotic specimens in order to 
evaluate differences, if any, in apolipoprotein profiles between circulating lipoproteins 
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COLLABORATION TO OTHER RESEARCH ACTIVITIES  
In parallel with the research activity described above, I took also part in other studies 
that have been published in various international journals. Some of these researches 
focused on several aspects of the atherosclerotic process, such as: 
- Evaluation of intra-plaque low molecular weight (LMW) thiols (page II):  
o association between LMW thiols levels in plaque and their corresponding 
plasma levels; 
o evaluation of the equilibrium between LMW thiols levels and intra-plaque 
protein thiolation. 
- New method for the quantification of LMW thiols bound to human albumin purified 
from different sources (plasma samples and atherosclerotic plaque extracts) by SDS-
PAGE (page III). 
- Relationship between plasma chondroitin sulfate level/structure and the 
presence/typology of the carotid atherosclerotic lesion (page IV).  
- Moreover, I participated as co-author to the preparation of a book chapter on an 
overview of latest advances in proteomic studies on atherosclerosis and some related 
diseases, with particular emphasis on vascular tissue proteomics and lipoproteomics 
(page V). 
Other researches focused on diverse topics such as: 
- Elucidating the complex relationships between inflammation markers and 
reproductive axis by analyzing the possible changes of circulating inflammatory plasma 
indicators such as C-reactive protein (CRP), leptin, and glycosaminoglycans (GAGs) in 
women with either ovulatory or anovulatory menstrual cycles (page VII). 
-Glycosaminoglycans content, distribution, and structure in porcine aortic and 
pulmonary valves and in pericardium before and after a detergent-based 
decellularization procedure utilized as xenograft in valvular replacement operations 
(page VIII). 
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Abstract 
Several studies have evidenced variations in plasma glycosaminoglycans content in 
physiological and pathological conditions. In normal human plasma GAGs are present 
mainly as undersulfated chondroitin sulfate (CS). The aim of the present study was to 
evaluate possible correlations between plasma CS level/structure and the 
presence/typology of carotid atherosclerotic lesion. Plasma CS was purified from 46 
control subjects and 47 patients undergoing carotid endarterectomy showing either a 
soft or a hard plaque. The concentration and structural characteristics of plasma CS 
were assessed by capillary electrophoresis of constituent unsatured fluorophore-labeled 
disaccharides. Results showed that the concentration of total CS isomers was increased 
of 21.4% (p<0.01) in plasma of patients, due to a significant increase of undersulfated 
CS. Consequently, in patients the plasma CS charge density was significantly reduced 
respect to that of controls. After sorting for plaque typology, we found that patients 
with soft plaques and those with hard ones differently contribute to the observed 
changes. In plasma from patients with soft plaques, the increase in CS content was not 
associated with modifications of its sulfation pattern. On the contrary, the presence of 
hard plaques was associated to CS sulfation pattern modifications in presence of quite 
normal total CS isomers levels. These results suggest that the plasma CS content and 
structure could be related to the presence and the typology of atherosclerotic plaque 
and could provide a useful diagnostic tool, as well as information on the molecular 
mechanisms responsible for plaque instability. 
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1. Introduction 
Cardiovascular diseases are the leading cause of mortality and morbidity in developed 
countries being atherosclerosis the major contributor. Atherosclerosis is a form of 
chronic inflammation characterized by the accumulation of lipids and fibrous elements 
in medium and large arteries (Libby, 2002). The retention of apoB-100 containing 
lipoproteins (mainly LDL and Lp(a)) in the subendothelial space and their subsequent 
oxidation is thought to be the leading event in the development of atherosclerotic 
lesions (Williams & Tabas, 1995). The degree of inflammation, proteolysis, calcification 
and neovascularization affects the stability of advanced lesions. Plaque rupture and 
thrombosis are the most important clinical complications in the pathogenesis of stroke, 
coronary arteries and peripheral vascular diseases (Lutgens et al., 2003). So, the 
identification of early biomarkers of plaque presence and susceptibility to ulceration 
could be of primary importance in preventing such a life-threatening event. Disease 
aetiology is very complex and includes several important environmental and genetic 
risk factors such as hyperlipidemia, diabetes, and hypertension. In this regard elevated 
plasma levels of LDL cholesterol and low levels of HDL cholesterol have been long 
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associated with the onset and development of atherosclerotic lesions. Although 
enormous efforts have been done to elucidate the molecular mechanisms underlying 
plaque formation and progression, they are not yet completely understood. In the last 
years, proteomic studies have been undertaken to both elucidate pathways of 
atherosclerotic degeneration and individuate new circulating markers to be utilized 
either as early diagnostic traits or as targets for new drug therapies. 
This chapter will provide an overview of latest advances in proteomic studies on 
atherosclerosis and some related diseases, with particular emphasis on vascular tissue 
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Abstract 
Cardiac valves are dynamic structures, undergoing cyclic mechanical stress, exhibiting 
a highly specialized architecture consisting of cells and extracellular matrix (ECM) with 
a relevant proteoglycan and glycosaminoglycan content, collagen and elastic fibers. 
Biological valve substitutes are obtained from xenogenic cardiac and pericardial tissues. 
To overcome the limits of such non-viable substitutes, tissue engineering approaches 
emerged to create cell repopulated decellularized ECM scaffolds. The present study 
was performed to determine the glycosaminoglycans content, distribution, and 
disaccharides composition in porcine aortic and pulmonary valves and in pericardium 
before and after a detergent-based decellularization procedure. The fine structural 
characteristics of galactosaminoglycans chondroitin sulfate (CS) and dermatan sulfate 
(DS) were examined by fluorophore-assisted carbohydrate electrophoresis. 
Furthermore, the mechanical properties of decellularized pericardium and its 
propensity to be repopulated by in vitro seeded fibroblasts were investigated. 
Results show that galactosaminoglycans (GalAGs) and hyaluronan (HA) are differently 
distributed between pericardium and valves and within heart valves themselves before 
and after decellularization. The distribution of glycosaminoglycans is also dependent 
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from the vascular district and topographic localization. In native leaflets and sinuses of 
both cardiac and pericardial valves the ???-??????? ???? ???-mono4S represent the 
major disaccharide types of GalAGs, followed by ?di-nonS, whereas lower proportions 
??????-diS were determined. In native pericardium, the vast majority of disaccharides, 
???-mono4S and ?di-diS, was resistant to degradation with chondroitinase AC II. The 
decellularization protocol adopted resulted in a relevant but not selective depletion of 
galactosaminoglycans. As a whole, data suggest that both decellularized porcine heart 
valves and bovine pericardium represent promising materials bearing the potential for 
future development of tissue engineered heart valve scaffolds. 
